CEO, Mitra Biotech
Dr Mallikarjun Sundaram co-founded Mitra Biotech, a Harvard-MIT spinoff in 2010. He serves as the President & CEO of the company since then. Prior to Mitra, Mallik was the scientific co-founder of Momenta Pharmaceuticals (Nasdaq: MNTA). Mallik obtained his Ph.D. in Biotechnology from the University of Utah, Salt Lake City and MBA from the Wharton Business School, University of Pennsylvania. He has been an adjunct faculty in the Department of Bioengineering (2000-2007) and the Department of Chemical Engineering (2007-present) at the Massachusetts Institute of Technology, Cambridge, MA. He has 12+ issued patents and 20+ publications in major peer reviewed academic journals.